Speaker illustration

Doctor Carly Adamson

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF

Event: ESC Congress 2022

Topic: Biomarkers

Session: SGLT2 inhibitors: pearls from recent trials and surveys

Thumbnail

Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - Prognosis and prediction of outcome

Thumbnail

This platform is supported by

logo Novo Nordisk